Journal article

Reduced blood pressure after smooth muscle EFNB2 deletion and the potential association of EFNB2 mutation with human hypertension risk

Y Wang, P Hamet, E Thorin, J Tremblay, J Raelson, Z Wu, H Luo, W Jin, JL Lavoie, J Peng, FC Marois-Blanchet, MR Tahir, J Chalmers, M Woodward, S Harrap, S Qi, CY Li, J Wu

European Journal of Human Genetics | NATURE PUBLISHING GROUP | Published : 2016

Abstract

Ephrin B2 (EFNB2) is a ligand for erythropoietin-producing hepatocellular kinases (EPH), the largest family of receptor tyrosine kinases. It has critical functions in many biological systems, but is not known to regulate blood pressure. We generated mice with a smooth muscle cell (SMC)-specific deletion of EFNB2 and investigated its roles in blood pressure regulation and vascular SMC (VSMC) contractility. Male Efnb2 knockout (KO) mice presented reduced blood pressure, whereas female KO mice had no such reduction. Both forward signaling from EFNB2 to EPHs and reverse signaling from EPHs to EFNB2 were involved in regulating VSMC contractility, with EPHB4 serving as a critical molecule for forw..

View full abstract

University of Melbourne Researchers

Grants

Awarded by Canadian Institutes of Health Research


Awarded by HL


Awarded by ET


Awarded by JT


Awarded by Natural Sciences and Engineering Research Council of Canada


Awarded by Juvenile Diabetes Research Foundation


Awarded by Fonds de recherche du Quebec-Sante


Funding Acknowledgements

This work was supported by grants from the Canadian Institutes of Health Research to JW (MOP57697, MOP69089 and MOP 123389), HL (MOP97829), ET (MOP14496) and JT (ISO106797). It was also funded by grants from the Heart and Stroke Foundation of Quebec, the Natural Sciences and Engineering Research Council of Canada (203906-2012), the Juvenile Diabetes Research Foundation (17-2013-440), the Fonds de recherche du Quebec-Sante (Ag-06) and the J-Louis Levesque Foundation to JW.